Have a personal or library account? Click to login
The impact of demographic and clinical characteristics on diabetic painful neuropathy Cover

References

  1. 1. BURSON LK, SCHANK CH. Charcot neuroarthropathy of the foot and ankle. Home healthcare now. 2016 Mar; 34(3):135–9.10.1097/NHH.000000000000034826925938
  2. 2. FOSSE S, HARTEMANN-HEURTIER A, JACQUEMINET S, HA VAN G, GRIMALDI A, FAGOT-CAMPAGNA A. Incidence and characteristics of lower limb amputations in people with diabetes. Diabet Med. 2009 Apr; 26(4):391–6.10.1111/j.1464-5491.2009.02698.x19388969
  3. 3. BECKMAN JA, CREAGER MA. Vascular complications of diabetes. Circulation Research. 2016 May 27; 118(11):1771–85.10.1161/CIRCRESAHA.115.30688427230641
  4. 4. POP-BUSUI R, BOULTON AJM, FELDMAN EL, BRIL V, FREEMAN R, MALIK RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017 Jan; 40 (1):136–154.10.2337/dc16-2042697740527999003
  5. 5. YAGIHASHI S, MIZUKAMI H. Diabetic neuropathy. In: Diabetes and Aging-related Complications. 2017 Jun 15; 8(6):249–269.
  6. 6. BOOYA F, BANDARIAN F, LARIJANI B, PAJOUHI M, NOORAEI M, LOTFI J. Potential risk factors for diabetic neuropathy: A case control study. BMC Neurol. 2005 Dec 10; 5:24.10.1186/1471-2377-5-24134357616336693
  7. 7. SMITH AG, SINGLETON JR. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. J Diabetes Complications. 2013 Sep–Oct; 27(5):436–42.10.1016/j.jdiacomp.2013.04.003376640423731827
  8. 8. ASLAM A, SINGH J, RAJBHANDARI S. Pathogenesis of painful diabetic neuropathy. Pain Research and Treatment. 2014 (4 i):412041.10.1155/2014/412041402698824891949
  9. 9. JAVED S, PETROPOULOS IN, ALAM U, MALIK RA. Treatment of painful diabetic neuropathy. Therapeutic Advances in Chronic Disease. 2015 Jan; 6(1):15–28.10.1177/2040622314552071426961025553239
  10. 10. PODWALL D, GOOCH C. Diabetic neuropathy: Clinical features, etiology, and therapy. Current Neurology and Neuroscience Reports. 2004 Jan; 4(1):55–61.10.1007/s11910-004-0013-914683630
  11. 11. LOZERON P, NAHUM L, LACROIX C, ROPERT A, GUGLIELMI JM, SAID G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol. 2002 May; 249(5):569–75.10.1007/s00415020006612021947
  12. 12. DOBRETSOV M, ROMANOVSKY D, STIMERS JR. Early diabetic neuropathy: Triggers and mechanisms. World Journal of Gastroenterology. 2007 Jan 14; 13(2):175–191.10.3748/wjg.v13.i2.175182941117226897
  13. 13. WON JC, PARK TS. Recent Advances in Diagnostic Strategies for Diabetic Peripheral Neuropathy. Endocrinol Metab. 2016 Jun; 31(2):230–8.10.3803/EnM.2016.31.2.230492340627246283
  14. 14. FELDMAN EL, STEVENS MJ, THOMAS PK, BROWN MB, CANAL N, GREENE DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994 Nov; 17(11):1281–9.10.2337/diacare.17.11.12817821168
  15. 15. BOULTON AJM, VINIK AI, AREZZO JC, BRIL V, FELDMAN EL, FREEMAN R, et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care. 2005 Apr; 28(4):956–62.10.2337/diacare.28.4.95615793206
  16. 16. PAPANAS N, VINIK AI, ZIEGLER D. Neuropathy in prediabetes: Does the clock start ticking early? Nature Reviews Endocrinology. 2011 Jul 12; 7(11):682–90.10.1038/nrendo.2011.11321750507
  17. 17. SINGLETON JR, SMITH AG, BROMBERG MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001 Aug; 24(8):1448–53.10.2337/diacare.24.8.144811473085
  18. 18. KHOSHNOODI MA, TRUELOVE S, BURAKGAZI A, HOKE A, MAMMEN AL, POLYDEFKIS M. Longitudinal assessment of small fiber neuropathy: Evidence of a non-length-dependent distal axonopathy. JAMA Neurol. 2016 Jun 1; 73(6):684–90.10.1001/jamaneurol.2016.005727065313
  19. 19. POURHAMIDI K, DAHLIN LB, ENGLUND E, ROLANDSSON O. No difference in small or large nerve fiber function between individuals with normal glucose tolerance and impaired glucose tolerance. Diabetes Care. 2013 Apr;36(4):962–4.10.2337/dc12-1331360948923223347
  20. 20. KAUR S, PANDHI P, DUTTA P. Painful diabetic neuropathy: An update. Ann Neurosci. 2011 Oct; 18(4):168–175.10.5214/ans.0972.7531.1118409
  21. 21. SNYDER MJ, GIBBS LM, LINDSAY TJ. Treating painful diabetic peripheral neuropathy: An update. Am Fam Physician. Aug 1; 94(3):227–34.
  22. 22. MIRANDA-MASSARI JR. B, GONZALEZ MJ. D, JIMENEZ FJ., ALLENDE-VIGO MZ., DUCONGE J. Metabolic correction in the management of diabetic peripheral neuropathy: Improving clinical results beyond symptom control. Curr Clin Pharmacol. 2011 Nov; 6(4):260–73.10.2174/157488411798375967368249822082324
  23. 23. GRISOLD A, CALLAGHAN BC, FELDMAN EL. Mediators of diabetic neuropathy. Curr Opin Endocrinol Diabetes Obes. 2017 Apr; 24(2):103–111.10.1097/MED.0000000000000320583154228098594
  24. 24. DIREÇÃO GERAL DE SAÚDE. Tratamento farmacológico da dor neuropática no adulto e idoso. Número 043/2011, atualizada a 13/07/2017. 2017
DOI: https://doi.org/10.2478/rjim-2019-0019 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 13 - 19
Submitted on: May 27, 2019
Published on: Mar 3, 2020
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 António Assunção, Dina Campos, Rui Marques, Inês Cunha, Patrícia Santos, Adriana Martins, Ana Sofia Gonçalves, Ana Rebelo, Carolina Lima, César Matos, Ana Cristina Prata, José Tiago Teixeira, Luís Duarte, Mariana Belo, Patrícia Figueiredo, Tiago Letras Rosa, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.